Article in Science advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
20 authors.
Dominique ArmstrongTranslation Biology and Molecular Medicine Program, Baylor College of Medicine, Houston, TX 77030, USA.ORCID 0000-0001-6669-0911
Cheng-Yen ChangTranslation Biology and Molecular Medicine Program, Baylor College of Medicine, Houston, TX 77030, USA.ORCID 0000-0002-3943-3044
Monica J HongDepartment of Medicine, Baylor College of Medicine, Houston, TX 77030, USA.ORCID 0000-0002-2123-3554
Linda GreenDepartment of Pathology, Michael E. DeBakey VA, Houston, TX 77030, USA.ORCID 0000-0003-2499-8816
Yichao ShenDepartment of Molecular & Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.
William HudsonDepartment of Molecular & Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.ORCID 0000-0002-2513-1213
Kelsey E MaukDepartment of Medicine, Baylor College of Medicine, Houston, TX 77030, USA.
Li-Zhen SongDepartment of Medicine, Baylor College of Medicine, Houston, TX 77030, USA.ORCID 0000-0002-2448-7795
Sheetal JammiDepartment of Medicine, Baylor College of Medicine, Houston, TX 77030, USA.
Benjamin CasalDepartment of Medicine, Baylor College of Medicine, Houston, TX 77030, USA.
Brianna BurnsDepartment of Pathology and Immunology, Baylor College of Medicine, Houston, TX 77030, USA.ORCID 0000-0002-6709-9581
Chad J CreightonDepartment of Medicine, Baylor College of Medicine, Houston, TX 77030, USA.ORCID 0000-0002-6090-703X
Alexandre CariseyDepartment of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA.ORCID 0000-0003-1326-2205
Xiang H-F ZhangDepartment of Molecular & Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.ORCID 0000-0002-5674-8670
Neil J McKennaDepartment of Molecular & Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.ORCID 0000-0001-6689-0104
Sung Wook KangDan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA.
Hyun-Sung LeeDan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA.ORCID 0000-0001-8259-046X
William DeckerDan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA.ORCID 0000-0003-0992-5838
David B CorryTranslation Biology and Molecular Medicine Program, Baylor College of Medicine, Houston, TX 77030, USA.ORCID 0000-0001-9729-1016
Farrah KheradmandTranslation Biology and Molecular Medicine Program, Baylor College of Medicine, Houston, TX 77030, USA.ORCID 0000-0001-5343-103X
Funding
Tumor BiologyP30CA125123 · NCI · BAYLOR COLLEGE OF MEDICINE · PI Suzanne AW Fuqua · 2007 to 2026
$73.9M
UM1HG006348: Cas9 Genome Integrity Supplemental ProposalUM1HG006348 · NHGRI · BAYLOR COLLEGE OF MEDICINE · PI Jason D. Heaney, Chih-Wei Logan Hsu · 2016 to 2026
$47.5M
METABOLIC IMPACTS OF TYPE II INTERFERON SIGNALS IN OBESITYR01DK114356 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI HARTIG, SEAN · 2017 to 2025
$4.6M
Regulation of Innate Dendritic Cell CTLA-4R01AI127387 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI WILLIAM Karl DECKER · 2017 to 2026
$3.9M
Pathogenesis of Polymicrobial Cerebritis-Related DementiaR01AI135803 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI CORRY, DAVID B, KHERADMAND, FARRAH · 2018 to 2022
$3.8M
Training Program in Translational Biology and Molecular MedicineT32GM088129 · NIGMS · BAYLOR COLLEGE OF MEDICINE · PI ROONEY, CLIONA M., VAN DEN VEYVER, IGNATIA B · 2010 to 2019
$3.0M
Role of Let-7 as genetic modifier of Alzheimer's DiseaseR01HL140398 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI CORRY, DAVID B, RODRIGUEZ, ANTONY · 2018 to 2022
$2.4M
Innate DC Govern TH Polarization through the Novel Regulator AIMp1R01AI153326 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI DECKER, WILLIAM KARL · 2021 to 2024
$2.3M
Toxic Effects of Ecigs Following Transition From Conventional CigarettesR01ES029442 · NIEHS · BAYLOR COLLEGE OF MEDICINE · PI KHERADMAND, FARRAH · 2018 to 2020
$1.6M
Th1 and Th17 Mediators in Experimental EmphysemaR01HL117181 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI CORRY, DAVID B, KHERADMAND, FARRAH · 2013 to 2016
$1.5M
BD Biosciences Special Order LSRIIS10RR024574 · NCRR · BAYLOR COLLEGE OF MEDICINE · PI LUMPKIN, ELLEN A · 2009 to 2009
Adaptive immunity is critical in eliminating tumors, but cancer-intrinsic factors can subvert this function. Melanoma antigen-A4 (MAGE-A4), a cancer-testis antigen, is expressed in solid tumors and correlates with poor survival, but its role in tumorigenesis and antitumor immunity remains unclear. We found that expression of MAGE-A4 was highly associated with the loss of
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
MAGE-A4 induces non-small cell lung cancer and tumor-promoting plasma cell accumulation. · full record | OpenQuestion